Therapeutic effect of nisin Z on subclinical mastitis in lactating cows

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 9, 2007, Pages 3131-3135

  Wu, Junqiang ^a   Hu, Songhua ^a   Cao, Liting ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; COTRIMOXAZOLE; GENTAMICIN; N ACETYL BETA GLUCOSAMINIDASE; NISIN; NORFLOXACIN; PENICILLIN G;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATTLE DISEASE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DAIRY CATTLE; DRUG EFFECT; ENZYME ACTIVITY; LACTATION; MASTITIS; MILK; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; TREATMENT DURATION;

ACETYLGLUCOSAMINIDASE; ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; CELL COUNT; FEMALE; IRRITANTS; LACTATION; MAMMARY GLANDS, ANIMAL; MASTITIS, BOVINE; MILK; NISIN;

EID: 35948938492     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00629-07     Document Type: Article

References (26)

1. Barkema, H. W., Y. H. Schukken, T. J. G. M. Lam, M. L. Beiboer, H. Wilmink, G. Benedictus, and A. Brand. 1998. Incidence of clinical mastitis in dairy herds grouped in three categories by bulk milk somatic cell counts. J. Dairy Sci. 81:411-419.
2. Baron, E. J., and S. M. Finegold. 1990. Bailey & Scott's diagnostic microbiology, 8th ed., p. 171-194. Mosby, St. Louis, MO.
3. Cai, W. M., S. H. Hu, and A. F. Du. 1993. Isolation of mastitis causing bacteria from dairy cows in Hangzhou region and drug sensitivity test. Chin. J. Vet. Technol. 23(5):21-22. (In Chinese.)
4. Carr, F. J., D. Chill, and N. Maida. 2002. The lactic acid bacteria: a literature survey. Crit. Rev. Microbiol. 28:281-370.
5. Deegan, L. H., P. D. Cotter, C. Hill, and P. Ross. 2006. Bacteriocins: biological tools for bio-preservation and shelf-life extension. Int. Dairy J. 16: 1058-1071.
6. Delves-Broughton, J., P. Blackburn, R. J. Evans, and J. Hugenholtz. 1996. Applications of the bacteriocin, nisin. Antonie Leeuwenhoek 69:193-202.
7. Dohoo, I. R., A. H. Meek, and S. W. Martin. 1984. Somatic cell counts in bovine milk: relationships to production and clinical episodes of mastitis. Can. J. Comp. Med. 48:130-135.
8. Gill, J. J., J. C. Pacan, M. E. Carson, K. E. Leslie, M. W. Griffiths, and P. M. Sabour. 2006. Efficacy and pharmacokinetics of bacteriophage therapy in treatment of subclinical Staphylococcus aureus mastitis in lactating dairy cattle. Antimicrob. Agents Chemother. 50:2912-2918.
9. Gill, R., W. H. Howard, K. E. Leslie, and K. Lissemore. 1990. Economics of mastitis control. J. Dairy Sci. 73:3340-3348.
10. Hulse, E. C., and J. E. Lancaster. 1951. The treatment with nisin of chronic bovine mastitis caused by Str. uberis and staphylococci. Vet. Rec. 63:477-480.
11. Lee, C. S., F. B. Wooding, and P. Kemp. 1980. Identification, properties, and differential counts of cell populations using electron microscopy of dry cows secretions, colostrum and milk from normal cows. J. Dairy Res. 47:39-50.
12. Miller, R. H., M. J. Paape, R. R. Peters, and D. M. Young. 1990. Total and differential somatic cell counts and N-acetyl-beta-D-glucosaminidase activity in mammary secretions during dry period. J. Dairy Sci. 73:1751-1755.
13. Ministry of Public Health of the People's Republic of China. 1996. Hygienic standards for the use of food additives (GB 2760-1996). Ministry of Public Health of the People's Republic of China, Beijing, China.
14. National Mastitis Council. 1999. Laboratory and field handbook on bovine mastitis, p. 11-19. National Mastitis Council, Inc., Arlington, VA.
15. Nielsen, N. I., T. Larsen, M. Bjerring, and K. L. Ingvartsen. 2005. Quarter health, milking interval, and sampling time during milking affect the concentration of milk constituents. J. Dairy Sci. 88:3186-3200.
16. Oliver, S. P., B. E. Gillespie, S. J. Headrick, H. Moorehead, P. Lunn, H. H. Dowlen, D. L. Johnson, K. C. Lamar, S. T. Chester, and W. M. Moseley. 2004. Efficacy of extended ceftiofur intramammary therapy for treatment of subclinical mastitis in lactating dairy cows. J. Dairy Sci. 87:2393-2400.
17. Pongtharangkul, T., and A. Demirci. 2004. Evaluation of agar diffusion bioassay for nisin quantification. Appl. Microbiol. Biotechnol. 65:268-272.
18. Pyorala, S. 1988. Indicators of inflammation to evaluate the recovery from acute bovine mastitis. Res. Vet. Sci. 45:166-169.
19. Ryan, M. P., W. J. Meaney, R. P. Ross, and C. Hill. 1998. Evaluation of lacticin 3147 and a teat seal containing this bacteriocin for inhibition of mastitis pathogens. Appl. Environ. Microbiol. 64:2287-2290.
20. Sears, P. M., B. S. Smith, W. K. Stewart, R. N. Gonzalez, S. D. Rubino, S. A. Gusik, E. S. Kulisek, S. J. Progran, and P. Blackburn. 1992. Evaluation of a nisin based germicidal formulation on teat skin of live cows. J. Dairy Sci. 75:3185-3190.
21. Sordillo, L. M., K. Shafer-Weaver, and D. DeRosa. 1997. Immunobiology of the mammary gland. J. Dairy Sci. 80:1851-1865.
22. Taylor, J., A. Hirsch, and A. T. R. Mattick. 1949. The treatment of bovine streptococcal and staphylococcal mastitis with nisin. Vet. Rec. 61:197-198.
23. Urech, E., Z. Puhan, and M. Schallibaum. 1999. Changes in milk protein fraction as affected by subclinical mastitis. J. Dairy Sci. 82:2402-2411.
24. U.S. Food and Drug Administration. 1988. Nisin preparation: affirmation of GRAS status as direct human food ingredient. Fed. Regist. 53:11247-11251.
25. Wang, F., L. T. Cao, and S. H. Hu. 2006. In vitro inhibitory effect of nisin on major pathogenic bacteria of bovine mastitis. Chin. J. Vet. Drug 40(10):12-16. (In Chinese.)
26. Wilson, D. J., P. M. Sears, R. N. Gonzalez, B. S. Smith, H. F. Schulte, G. J. Bennett, H. H. Das, and C. K. Johnson. 1996. Efficacy of florfenicol for treatment of clinical and subclinical bovine mastitis. Am. J. Vet. Res. 57:526-528.